Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25

Nature Communications

Volumn 2, Issue 1, 2011, Pages

  Nakamura, Yukio ^a   Yamamoto, Koji ^b   He, Xinjun ^c   Otsuki, Bungo ^b   Kim, Youngwoo ^b   Murao, Hiroki ^b   Soeda, Tsunemitsu ^b   Tsumaki, Noriyuki ^d   Deng, Jian Min ^e   Zhang, Zhaoping ^e   Behringer, Richard R ^e   De Crombrugghe, Benoit ^e   Postlethwait, John H ^c   Warman, Matthew L ^f   Nakamura, Takashi ^b   Akiyama, Haruhiko ^b  

^a NATIONAL HOSPITAL ORGANIZATION MURAYAMA MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF OREGON   (United States)

^d OSAKA UNIVERSITY   (Japan)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN; PROTEIN WWP2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; MED25 PROTEIN, HUMAN; MEDIATOR COMPLEX; MORPHOLINE DERIVATIVE; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; SOX9 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE; WWP2 PROTEIN, MOUSE;

ANIMAL TISSUE; ARTICLE; CHONDROGENESIS; CONTROLLED STUDY; DNA LIBRARY; EMBRYO; GENE SILENCING; GENE TRANSLOCATION; MOUSE; NONHUMAN; PALATE; PROTEIN BINDING; PROTEIN INTERACTION; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM; YEAST; ZEBRA FISH; ANIMAL; ANIMAL EMBRYO; CAMPOMELIC DYSPLASIA; CARTILAGE; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PRENATAL DEVELOPMENT; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE;

DANIO RERIO;

ANIMALS; CAMPOMELIC DYSPLASIA; CARTILAGE; CELL LINE; CHONDROGENESIS; EMBRYO, MAMMALIAN; EMBRYO, NONMAMMALIAN; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; MEDIATOR COMPLEX; MICE; MICE, TRANSGENIC; MORPHOLINES; MUTATION; PALATE; PROTEIN BINDING; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASES; ZEBRAFISH;

EID: 79953242601     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1242     Document Type: Article

References (35)

1. Akiyama, H., Chaboissier, M. C., Martin, J. F., Schedl, A. & de Crombrugghe, B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes. Dev. 16, 2813-2828 (2002). (Pubitemid 35253149)
2. Akiyama, H. et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes. Dev. 18, 1072-1087 (2004). (Pubitemid 38620246)
3. Wagner, T. et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111-1120 (1994).
4. Foster, J. W. et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372, 525-530 (1994). (Pubitemid 24368528)
5. Benko, S. et al. Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat. Genet. 41, 359-364 (2009).
6. Bi, W. et al. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl Acad. Sci. USA 98, 6698-6703 (2001). (Pubitemid 32538279)
7. Smits, P. et al. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev. Cell. 1, 277-290 (2001). (Pubitemid 33653062)
8. Lefebvre, V., Li, P. & de Crombrugghe, B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17, 5718-5733 (1998). (Pubitemid 28445983)
9. Han, Y. & Lefebvre, V. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol. Cell Biol. 28, 4999-5013 (2008).
10. Nikopensius, T. et al. Genetic variants in COL2A1, COL11A2, and IRF6 contribute risk to nonsyndromic cleft palate. Birth Defects Res. A Clin. Mol. Teratol. 88, 748-756 (2010).
11. Melkoniemi, M. et al. Collagen XI sequence variations in nonsyndromic cleft palate, Robin sequence and micrognathia. Eur. J. Hum. Genet. 11, 265-270 (2003). (Pubitemid 36511864)
12. Watanabe, H. et al. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat. Genet. 7, 154-157 (1994). (Pubitemid 24174653)
13. Tsuda, M., Takahashi, S., Takahashi, Y. & Asahara, H. Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J. Biol. Chem. 278, 27224-27229 (2003). (Pubitemid 36876879)
14. Rau, M. J., Fischer, S. & Neumann, C. J. Zebrafish Trap230/Med12 is required as a coactivator for Sox9-dependent neural crest, cartilage and ear development. Dev. Biol. 296, 83-93 (2006). (Pubitemid 44061756)
15. Zhou, R. et al. SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex. Nucleic. Acids Res. 30, 3245-3252 (2002). (Pubitemid 34846188)
16. Hata, K. et al. Paraspeckle protein p54nrb links Sox9-mediated transcription with RNA processing during chondrogenesis in mice. J. Clin. Invest. 118, 3098-3108 (2008).
17. Hattori, T. et al. Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res. 36, 3011-3024 (2008). (Pubitemid 351737193)
18. Rotin, D. & Kumar, S. Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 10, 398-409 (2009).
19. McDonald, F. J. et al. Ubiquitin-protein ligase WWP2 binds to and downregulates the epithelial Na(+) channel. Am. J. Physiol. Renal. Physiol. 283, F431-436 (2002).
20. Foot, N. J. et al. Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2. Blood 112, 4268-4275 (2008).
21. Xu, H. M. et al. Wwp2, an E3 ubiquitin ligase that targets transcription factor Oct-4 for ubiquitination. J. Biol. Chem. 279, 23495-23503 (2004). (Pubitemid 38685661)
22. Mertin, S., McDowall, S. G. & Harley, V. R. The DNA-binding specificity of SOX9 and other SOX proteins. Nucleic Acids Res. 27, 1359-1364 (1999). (Pubitemid 29206447)
23. Yan, Y. L. et al. A pair of Sox: distinct and overlapping functions of zebrafish sox9 co-orthologs in craniofacial and pectoral fin development. Development 132, 1069-1083 (2005).
24. Macias, M. J. et al. Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature 382, 646-649 (1996).
25. Yang, F., DeBeaumont, R., Zhou, S. & Naar, A. M. The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator. Proc. Natl Acad. Sci. USA 101, 2339-2344 (2004). (Pubitemid 38269313)
26. Lee, H. K., Park, U. H., Kim, E. J. & Um, S. J. MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. EMBO J. 26, 3545-3557 (2007).
27. Leal, A. et al. Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics 10, 275-287 (2009).
28. Martin-Serrano, J., Eastman, S. W., Chung, W. & Bieniasz, P. D. HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J. Cell Biol. 168, 89-101 (2005). (Pubitemid 40111060)
29. Murillas, R., Simms, K. S., Hatakeyama, S., Weissman, A. M. & Kuehn, M. R. Identification of developmentally expressed proteins that functionally interact with Nedd4 ubiquitin ligase. J. Biol. Chem. 277, 2897-2907 (2002). (Pubitemid 34953323)
30. Zou, W. et al. The E3 ubiquitin ligase Wwp2 regulates craniofacial development through mono-ubiquitylation of Goosecoid. Nat. Cell Biol. 13, 59-65 (2010).
31. Rana, R., Surapureddi, S., Kam, W., Ferguson, S. & Goldstein, J. A. Med25 is required for RNA polymerase II recruitment to specific promoters, thus regulating xenobiotic and lipid metabolism in human liver. Mol. Cell Biol. 31, 466-481 (2011).
32. Akiyama, H. et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl Acad. Sci. USA 102, 14665-14670 (2005). (Pubitemid 41457113)
33. Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R. & de Crombrugghe, B. Sox9 is required for cartilage formation. Nat. Genet. 22, 85-89 (1999). (Pubitemid 29214811)
34. Walker, M. B. & Kimmel, C. B. A two-color acid-free cartilage and bone stain for zebrafish larvae. Biotech. Histochem. 82, 23-28 (2007). (Pubitemid 46839257)
35. Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N. & de Crombrugghe, B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell Biol. 17, 2336-2346 (1997). (Pubitemid 27133320)